MAB-1031

N/A

Report date: 2024/10/31 09:56:51

Base Information

Drug NameMAB-1031
Drug Alias NameMAB1031MAB-1031
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionADAM Metallopeptidase Domain 8 inhibitors
TargetsADAM Metallopeptidase Domain 8
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A